Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Diabetes
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Interview: Philippe Froguel
5
Mins
October 2024
Today, the priority populations to target to prevent diabetes should be young adults who have inadequate diets. This information should guide public health action to prevent diabetes.
Read more
9
Mins
31st October 2017
Type 2 Diabetes Mellitus and Stem Cell Therapy: A Review
Most public health statistics outline the rapidly exploding burden of Type 2 diabetes mellitus as a chronic endemic disease related to sedentary…
9
Mins
31st October 2017
Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Effective?
Diabetic macular oedema is a common ocular problem among patients with diabetic retinopathy, that is sight-threatening and leads to blindness
9
Mins
31st October 2017
Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Safe?
Over the last decade, intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents have been increasingly used in the management of various…
9
Mins
2nd March 2017
Cardiovascular Risk Factor Control in Type 2 Diabetes Mellitus and New Trial Evidence
The micro and macrovascular complications of Type 2 diabetes mellitus are influenced by several well described cardiovascular risk factors such as…
13th December 2016
Sedentary Behaviour: A New Target in the Prevention and Management of Diabetes?
Since the early 2000s, an increasing number of studies have focussed on the adverse health effects of sitting. Sitting, together with other activities…
13th December 2016
Management of Cardiovascular Risk Factors in Type 2 Diabetes Mellitus Patients
People with Type 2 diabetes mellitus (T2DM), compared with non-diabetic individuals, have increased cardiovascular risk. Part of this excess risk is…
13
Mins
27th October 2016
Type 2 Diabetes Mellitus: Beyond the Beta Cell
Type 2 diabetes mellitus (T2DM) currently affects >8% of the world population. It is the leading cause of blindness, end-stage kidney disease, and…
9
Mins
27th October 2016
Editor’s Pick: New Drugs for Type 2 Diabetes: New Hopes and New Concerns About the Skeleton
There is growing evidence indicating the effects of medications for Type 2 diabetes mellitus (T2DM) on bone metabolism and fracture risk.
Loading posts...
« Previous
1
…
10
11
12
13
14
…
16
Next »